We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Open Orphan Plc | LSE:ORPH | London | Ordinary Share | GB00B9275X97 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.00 | 9.50 | 10.50 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
22/1/2021 08:11 | Sell price and buy price now both the same. Masking trades was it a buy or was it a sell .. interesting . | jeanesy | |
22/1/2021 08:11 | L2 Market opening a lot more positive. Hopefully seller doesnt show. | john henry | |
22/1/2021 08:07 | Sell price now 24.5 despite the quote. hold onto those shares folks | jeanesy | |
22/1/2021 08:04 | In for a few more... it would be rude not to ! | jeanesy | |
22/1/2021 07:48 | Judi, A data-led CRO generating data? Looks like a virtuous circle to me. G. | garth | |
22/1/2021 07:38 | Excellent, both will do me | discojames | |
22/1/2021 06:16 | It’s say’s above that that the management are primarily focussed on cementing Orph’s position as a unique CRO company When in fact CF has publicly stated he wants Orph to be primarily a data focused company Surely they can’t be one and the same 🤷a | judijudi | |
22/1/2021 01:06 | Taken from Vox Markets, just published earlier today, a reminder of the potential that's not priced in either. Planned DisposalWhen Open Orphan acquired hVIVO in January 2020, hVIVO also came with a number of non-core assets including a 62.6% stake in PrEP Biopharm. However, the new Open Orphan Board and management team are primarily focussed upon cementing its position as a unique CRO and 'world leader vaccine and antiviral testing using human challenge study models, and therefore earmarked all non-core assets for disposal.The options for disposal of this unique asset are exciting, numerous and particularly timely given its mode of action. These options could include a trade sale to a Big-Pharma for cash, reverse the asset into the resurgence of listed SPACs and Cash Shells, or even Spin the asset out into a newly listed entity delivering investors dividends in specie of newly formed companies.In any event, OPRH shareholders would do well to remain on the Shareholder register when this transaction takes place as, whilst the valuation of PrEP Biopharm is currently unknown, with little carrying value on the Open Orphan balance sheet, it should advance the share price accordingly. | ross k | |
21/1/2021 22:34 | NHS dishing out wearables to the over 65s. Mentioned that could happen some months ago. Currently just oxygen monitors which tell you to go to hospital or your gp if levels drop below 92%. iirc. A bit more software, a bit more hardware, a disease progression database and the nhs could have a comprehensive early warning system for several diseaes, including covid. Could save lives and lots of nhs cash with early detection and treatment. | pierre oreilly | |
21/1/2021 21:05 | Lako, we don’t have to wait they will probably say it is too much money and will costs us more in accounting fees... | mark10101 | |
21/1/2021 21:02 | Already prices in from last year. | slartybartfaster | |
21/1/2021 20:50 | I look forward to seeing what weird, negative and underlying meaning someone can assign to it. | lako42 | |
21/1/2021 20:35 | Do u notice how all nay sayers disappear when some positive news is found or released. Tomorrow morning wethers there's a rns or not I suspect it will be used by many to buy or add. I did yesterday. | ross k | |
21/1/2021 20:00 | disco and jim - I do know what UT is and certainly am not a lazy punter. Been here since 13p days. | digger2779 | |
21/1/2021 19:52 | Hats off to you rivaldo for finding that. Surely a confirmational RNS in the morning. If not time to add to an already overweight position. A great day all round with AAZ surging on today's news. That was known by those that follow the company for some time but the market didn't take notice until it was Rn'sd today. I think the same will happen here :) | jeanesy | |
21/1/2021 19:30 | ...so here’s confirmation of the £46million NHS Challenge Study Contract?? | adorling | |
21/1/2021 17:47 | Doesn’t stagger me - too many lazy punters - only takes 2 mins to learn what they are | jimzi | |
21/1/2021 17:42 | A UT is not a buy nor a sell, staggers me how many people dont understand what it is | discojames | |
21/1/2021 17:39 | I presume this means ethical approval granted or the contract wouldn't have been finalised | drmaccers | |
21/1/2021 17:38 | Maybe look down and see the 46mill contract signed off by the gov mate | drmaccers | |
21/1/2021 17:11 | See today's UT is bigger than yesterday's lol. I think it is a delayed sell so not expecting anything tomorrow other than another down day. | digger2779 | |
21/1/2021 17:03 | Unless they want to keep the lid on the shareprice of course... | 1gw | |
21/1/2021 17:00 | They have already announced it of course, but headlined as £10m at the time plus the 3 deposits of £7.5m total. So they have the option of RNS-ing a bit more detail and headlining the £46m, perhaps together with an update on progress with characterisation, ethical approvals and recruitment? | 1gw | |
21/1/2021 16:58 | Ahhh ignore me. It is the same work but looks like it's been singed off? | lako42 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions